MYFORTIC 360 mg, gastro-resistant tablet 120 tablets
Active ingredients: Mycophenolic acid, Mycophenolate sodium
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant tablet120 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MYFORTIC 360 mg, comprimé gastro-résistant
- Pharmaceutical form
- comprimé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- 12 plaquette(s) polyamide aluminium PVC de 10 comprimé(s)
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Mar 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67858369CIP73630919CIP133400936309197Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MYCOPHÉNOLATE SODIQUEcomprimé | — | SA |
| ACIDE MYCOPHÉNOLIQUEcomprimé | 360 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.